Novartis gets positive result from breast-cancer drug trial

The Phase 3 trial, named Natalee, was stopped early as the primary endpoint has been met, Novartis said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.